Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ceplene
2. Histamine
3. Histamine Hydrochloride
4. Peremin
1. 56-92-8
2. Histamine 2hcl
3. Ceplene
4. Peremin
5. 1h-imidazole-4-ethanamine Dihydrochloride
6. 2-(1h-imidazol-4-yl)ethanamine Dihydrochloride
7. 1h-imidazole-4-ethanamine, Dihydrochloride
8. 2-(4-imidazolyl)ethylamine Dihydrochloride
9. 2-(1h-imidazol-4-yl)ethylamine Dihydrochloride
10. Histaminedihydrochloride
11. Mfcd00012703
12. Histamine Chloride
13. Histamine Dihcl
14. Histamine Dichloride
15. Histamine Dihydrochloride [usan]
16. 2-imidazol-4-ylethylamine Dihydrochloride
17. Histaminedium Dichloride
18. Histamine Hcl
19. 4-(2-aminoethyl)imidazole Dihydrochloride
20. Histamine Dichlorhydrate
21. Histaminum Hydrochloricum
22. 2-(1h-imidazol-5-yl)ethanamine Dihydrochloride
23. Histamine (dihydrochloride)
24. 2-(1h-imidazol-4-yl)ethan-1-amine Dihydrochloride
25. Histamine, Dihydrochloride
26. 3poa0q644u
27. Nsc-257873
28. 1h-imidazole-5-ethanamine, Hydrochloride (1:2)
29. Bichlorhydrated'histamine
30. Histamine Dihydrochloride (usan)
31. 2-(1h-imidazol-4-yl)ethanamine;dihydrochloride
32. Sr-01000075270
33. Bichlorhydrate D'histamine [french]
34. Einecs 200-298-4
35. Bichlorhydrate D'histamine
36. Nsc 257873
37. Unii-3poa0q644u
38. Ai3-24394
39. Ceplene (tn)
40. Histamine Dihydrocloride
41. 2-(1h-imidazol-5-yl)ethanamine;dihydrochloride
42. C5h9n3.2hcl
43. Schembl58710
44. Spectrum1500331
45. Chembl1533310
46. Dtxsid1058767
47. Schembl16778301
48. Timtec-bb Sbb003722
49. Hms1920d11
50. Act02743
51. Bcp16313
52. Hy-b0722
53. Str02021
54. Tox21_500595
55. Ccg-38567
56. Mfcd08060928
57. S4118
58. Histamine Dihydrochloride [mi]
59. Akos015894236
60. Akos016353223
61. Ac-7507
62. Bs-3141
63. Cs-w020699
64. Histamine Hydrochloride [mart.]
65. Ks-5310
66. Lp00595
67. Histamine Hydrochloride [who-dd]
68. Histaminum Hydrochloricum [hpus]
69. Ncgc00093973-01
70. Ncgc00093973-02
71. Ncgc00093973-03
72. Ncgc00261280-01
73. 2-(4-imidazolyl)ethylaminedihydrochloride
74. 4-(2-aminoethyl)imidazole Dihydorchloride
75. Bp-12001
76. Histamine Dihydrochloride [usp-rs]
77. Sy012860
78. Db-019204
79. Histamine Dihydrochloride [ema Epar]
80. Histamine Dihydrochloride, >=99.0% (at)
81. Eu-0100595
82. Ft-0627074
83. H0146
84. Sw219552-1
85. En300-75558
86. 4-(2-aminoethyl)-1h-imidazole Dihydrochloride
87. D04444
88. Edihydrochlorideavailablefrom1kgto100kg.
89. H 7250
90. H-2250
91. H-2255
92. Histamine Dihydrochloride [ep Monograph]
93. 012h703
94. A831236
95. Histamine Dihydrochloride, >=99% (tlc), Powder
96. 1h-imidazole-4-ethanamine, Chloride (1:1)
97. 2-(1h-imidazol-5-yl)ethan-1-amine Dihydrochloride
98. Q5772985
99. Sr-01000075270-1
100. Sr-01000075270-7
101. Histamine Dihydrochloride, Tested According To Ph Eur
102. F2191-0277
103. Histamine Dihydrochloride, Saj Special Grade, >=98.0%
104. Histamine Dihydrochloride, Vetec(tm) Reagent Grade, 98%
105. Z1267773750
106. 2-(1h-imidazol-5-yl)ethanamine Dihydrochloride, Aldrichcpr
107. 2-(1h-imidazol-5-yl)ethanamine Hydrochloride (1:1)
108. Histamine Dihydrochloride 100 Microg/ml In Acetonitrile:water
109. Histamine Dihydrochloride, European Pharmacopoeia (ep) Reference Standard
110. Allergen Scratch Extract Positive Control 'torii' Histamine Dihydrochloride
111. Histamine Dihydrochloride, United States Pharmacopeia (usp) Reference Standard
112. 2-(4-imidazolyl)ethylamine Dihydrochloride; 2-(1h-imidazol-4-yl)ethylamine Dihydrochloride;histamine 2hcl
1. Ergamine
2. Ergotidine
Molecular Weight | 184.06 g/mol |
---|---|
Molecular Formula | C5H11Cl2N3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 183.0330028 g/mol |
Monoisotopic Mass | 183.0330028 g/mol |
Topological Polar Surface Area | 54.7 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 64.7 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (IL-2). The efficacy of Ceplene has not been fully demonstrated in patients older than age 60.
Histamine Agonists
Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. (See all compounds classified as Histamine Agonists.)
L03AX14
L - Antineoplastic and immunomodulating agents
L03 - Immunostimulants
L03A - Immunostimulants
L03AX - Other immunostimulants
L03AX14 - Histamine dihydrochloride
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Histamine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Histamine Dihydrochloride, including repackagers and relabelers. The FDA regulates Histamine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Histamine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Histamine Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Histamine Dihydrochloride supplier is an individual or a company that provides Histamine Dihydrochloride active pharmaceutical ingredient (API) or Histamine Dihydrochloride finished formulations upon request. The Histamine Dihydrochloride suppliers may include Histamine Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Histamine Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Histamine Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Histamine Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Histamine Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Histamine Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Histamine Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Histamine Dihydrochloride USDMF includes data on Histamine Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Histamine Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Histamine Dihydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Histamine Dihydrochloride Drug Master File in Japan (Histamine Dihydrochloride JDMF) empowers Histamine Dihydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Histamine Dihydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Histamine Dihydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Histamine Dihydrochloride suppliers with JDMF on PharmaCompass.
A Histamine Dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Histamine Dihydrochloride Certificate of Suitability (COS). The purpose of a Histamine Dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Histamine Dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Histamine Dihydrochloride to their clients by showing that a Histamine Dihydrochloride CEP has been issued for it. The manufacturer submits a Histamine Dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Histamine Dihydrochloride CEP holder for the record. Additionally, the data presented in the Histamine Dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Histamine Dihydrochloride DMF.
A Histamine Dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Histamine Dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Histamine Dihydrochloride suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Histamine Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Histamine Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Histamine Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Histamine Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Histamine Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Histamine Dihydrochloride suppliers with NDC on PharmaCompass.
Histamine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Histamine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Histamine Dihydrochloride GMP manufacturer or Histamine Dihydrochloride GMP API supplier for your needs.
A Histamine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Histamine Dihydrochloride's compliance with Histamine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Histamine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Histamine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Histamine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Histamine Dihydrochloride EP), Histamine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Histamine Dihydrochloride USP).
LOOKING FOR A SUPPLIER?